NSC |
Compound |
Enrichment |
Correlation |
NSC 23416 |
Null |
0.0267520285931239 |
0.50509653 |
NSC 321206 |
Null |
0.0267520285931239 |
0.38441943 |
NSC 335794 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide |
0.0267520285931239 |
0.51407463 |
NSC 382386 |
2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- |
0.0267520285931239 |
-0.23191106 |
NSC 617823 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.0267520285931239 |
0.57522266 |
NSC 622282 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.0267520285931239 |
0.54589192 |
NSC 628916 |
3-(3,N,N-diethylaminopropylamino)-1,2,4-benzotriazine 1,4-dioxide. 0.33 Hydrate |
0.0267520285931239 |
0.09375007 |
NSC 637993 |
6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride |
0.0267520285931239 |
0.36869486 |
NSC 654379 |
ANTINEOPLASTIC-654379 |
0.0267520285931239 |
0.53145514 |
NSC 657270 |
(+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate |
0.0267520285931239 |
0.21393781 |